Streamlined.financeStreamlined.finance
MarketsFind Stocks

Abbott Laboratories

NYSE

Market Cap.

200.33B

Avg. Volume

5.08M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Abbott Laboratories

Abbott Laboratories News

Abbott Laboratories Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Devices
abbott.com

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories Earnings & Revenue

Abbott Laboratories Financials

Table Compare

Compare ABT metrics with:

   

Earnings & Growth

ABT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ABT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ABT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ABT

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Abbott Laboratories Income

Abbott Laboratories Balance Sheet

Abbott Laboratories Cash Flow

Abbott Laboratories Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Abbott Laboratories Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.2000

Payment DateDividendFrequency
2024-11-150.55Quarterly
2024-08-150.55Quarterly
2024-05-150.55Quarterly
2024-02-150.55Quarterly
2023-11-150.51Quarterly

Abbott Laboratories Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Abbott Laboratories Executives

NameRole
Mr. Robert B. FordChairman of the Board, President & Chief Executive Officer
Mr. Hubert L. Allen J.D.Executive Vice President, General Counsel & Secretary
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical Devices
Mr. Philip P. BoudreauChief Financial Officer & Executive Vice President of Finance
NameRoleGenderDate of BirthPay
Mr. Robert B. FordChairman of the Board, President & Chief Executive OfficerMale19744.73M
Mr. Hubert L. Allen J.D.Executive Vice President, General Counsel & SecretaryMale19662M
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional ProductsMale19791.76M
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical DevicesFemale19701.73M
Mr. Philip P. BoudreauChief Financial Officer & Executive Vice President of FinanceMale19731.14M

Abbott Laboratories Insider Trades

Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionAcquired
TypeM-Exempt
Shares157421
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares1249
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares5901
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares150271
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeM-Exempt
Shares157421
DateNameRoleTransactionTypeShares
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTAcquiredM-Exempt157421
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale1249
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale5901
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale150271
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedM-Exempt157421

Discover More

Streamlined Academy

Abbott Laboratories

NYSE

Market Cap.

200.33B

Avg. Volume

5.08M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Abbott Laboratories News

Abbott Laboratories Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Abbott Laboratories Earnings & Revenue

Abbott Laboratories Income

Abbott Laboratories Balance Sheet

Abbott Laboratories Cash Flow

Abbott Laboratories Financials Over Time

Abbott Laboratories Executives

NameRole
Mr. Robert B. FordChairman of the Board, President & Chief Executive Officer
Mr. Hubert L. Allen J.D.Executive Vice President, General Counsel & Secretary
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical Devices
Mr. Philip P. BoudreauChief Financial Officer & Executive Vice President of Finance
NameRoleGenderDate of BirthPay
Mr. Robert B. FordChairman of the Board, President & Chief Executive OfficerMale19744.73M
Mr. Hubert L. Allen J.D.Executive Vice President, General Counsel & SecretaryMale19662M
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional ProductsMale19791.76M
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical DevicesFemale19701.73M
Mr. Philip P. BoudreauChief Financial Officer & Executive Vice President of FinanceMale19731.14M

Abbott Laboratories Insider Trades

Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionAcquired
TypeM-Exempt
Shares157421
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares1249
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares5901
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares150271
Date21 Oct
NameALLEN HUBERT L
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeM-Exempt
Shares157421
DateNameRoleTransactionTypeShares
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTAcquiredM-Exempt157421
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale1249
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale5901
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedS-Sale150271
21 OctALLEN HUBERT LEXECUTIVE VICE PRESIDENTDisposedM-Exempt157421

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
abbott.com

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Abbott Laboratories

Abbott Laboratories Financials

Table Compare

Compare ABT metrics with:

   

Earnings & Growth

ABT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ABT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ABT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ABT

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Abbott Laboratories Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.2000

Payment DateDividendFrequency
2024-11-150.55Quarterly
2024-08-150.55Quarterly
2024-05-150.55Quarterly
2024-02-150.55Quarterly
2023-11-150.51Quarterly

Abbott Laboratories Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)